Calculation of Bioavailability Parameters. Objectives. Determine of ka. 20 July Chapter Estimation

Similar documents
PHAR 7633 Chapter 19 Multi-Compartment Pharmacokinetic Models

PHAR 7633 Chapter 22 Non-Linear Regression Analysis of Pharmacokinetic Data Individual Data and Population Analysis

PHAR 7633 Chapter 21 Non-Linear Pharmacokinetic Models

IV solutions may be given either as a bolus dose or infused slowly through a vein into the plasma at a constant or zero-order rate.

Overview of Dissolution for BA/BE

Absorption of Drugs. Transport of a drug from the GI tract

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS

Oral Bioavailability of Creatine Supplements: Is There Room for Improvement?

MAT 274 HW 2 Solutions c Bin Cheng. Due 11:59pm, W 9/07, Points

BIOAVAILABILITY & BIOEQUIVALENCE TRIALS

Georgia Department of Education Common Core Georgia Performance Standards Framework Teacher Edition Coordinate Algebra Unit 4

1: CLINICAL PHARMACOKINETICS

The Rate and Extent of Calcium Bioavailability from Two Oral Dosage Forms in Rats

EXPERIMENT 11 UV/VIS Spectroscopy and Spectrophotometry: Spectrophotometric Analysis of Potassium Permanganate Solutions.

Oscillations. Vern Lindberg. June 10, 2010

Clovis Community College Core Competencies Assessment Area II: Mathematics Algebra

Simple Methods and Procedures Used in Forecasting

Section 14 Simple Linear Regression: Introduction to Least Squares Regression

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

Bioavailability / Bioequivalence

Experiment #1, Analyze Data using Excel, Calculator and Graphs.

Logs Transformation in a Regression Equation

Dynamical Systems Analysis II: Evaluating Stability, Eigenvalues

Fixed Point Theorems

Solutions to Linear First Order ODE s

Chemical Kinetics. 2. Using the kinetics of a given reaction a possible reaction mechanism

We extended the additive model in two variables to the interaction model by adding a third term to the equation.

User Guide Thank you for purchasing the DX90

correct-choice plot f(x) and draw an approximate tangent line at x = a and use geometry to estimate its slope comment The choices were:

Chapter 9. The IS-LM/AD-AS Model: A General Framework for Macroeconomic Analysis Pearson Addison-Wesley. All rights reserved

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

Homework 8 Solutions

To Be or Not To Be a Linear Equation: That Is the Question

Analysis of Stresses and Strains

A Peak at PK An Introduction to Pharmacokinetics

k L a measurement in bioreactors

Unit 31 A Hypothesis Test about Correlation and Slope in a Simple Linear Regression

Introduction to Enteris BioPharma

The KaleidaGraph Guide to Curve Fitting

A power series about x = a is the series of the form

Reaction of Blue Food Dye with Bleach

Nursing 113. Pharmacology Principles

Study (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética

Particular Solutions. y = Ae 4x and y = 3 at x = 0 3 = Ae = A y = 3e 4x

Linear Regression. Chapter 5. Prediction via Regression Line Number of new birds and Percent returning. Least Squares

Homework #2 Solutions

5.5 Pharmacokinetics - Sublingual

8. Time Series and Prediction

Reaction Rates and Chemical Kinetics. Factors Affecting Reaction Rate [O 2. CHAPTER 13 Page 1

Preparation of core-shell magnetic nanoparticles for biosensor construction. Supplementary materials

Calculus AB 2014 Scoring Guidelines

6. Differentiating the exponential and logarithm functions

HIBBING COMMUNITY COLLEGE COURSE OUTLINE


Statistics and Pharmacokinetics in Clinical Pharmacology Studies

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.

Algebra II Notes Piecewise Functions Unit 1.5. Piecewise linear functions. Math Background

Data Mining Part 5. Prediction

Logistic Regression (a type of Generalized Linear Model)

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure

First Order Circuits. EENG223 Circuit Theory I

Decentralised Procedure. Public Assessment Report

1) Write the following as an algebraic expression using x as the variable: Triple a number subtracted from the number

LOGIT AND PROBIT ANALYSIS

Introduction To Materials Science FOR ENGINEERS, Ch. 5. Diffusion. MSE 201 Callister Chapter 5

MGT 267 PROJECT. Forecasting the United States Retail Sales of the Pharmacies and Drug Stores. Done by: Shunwei Wang & Mohammad Zainal

Worksheet A5: Slope Intercept Form

2) The three categories of forecasting models are time series, quantitative, and qualitative. 2)

Statistical Models in R

x = + x 2 + x

Absorbance Spectrophotometry: Analysis of FD&C Red Food Dye #40 Calibration Curve Procedure

Theory at a Glance (For IES, GATE, PSU)

To add fractions we rewrite the fractions with a common denominator then add the numerators. = +

TIME SERIES ANALYSIS & FORECASTING

Demand forecasting & Aggregate planning in a Supply chain. Session Speaker Prof.P.S.Satish

Introduction to Error Analysis

Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV

Aim: How do we find the slope of a line? Warm Up: Go over test. A. Slope -

Semi-Log Model. Semi-Log Model

Using R for Linear Regression

table to see that the probability is (b) What is the probability that x is between 16 and 60? The z-scores for 16 and 60 are: = 1.

UV-VIS SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF GABAPENTIN AND METHYLCOBALAMIN IN BULK AND TABLET

Regression III: Advanced Methods

Guidance for Industry

Microeconomic Theory: Basic Math Concepts

PRACTICE FINAL. Problem 1. Find the dimensions of the isosceles triangle with largest area that can be inscribed in a circle of radius 10cm.

Kinetic studies using UV-VIS spectroscopy Fenton reaction

QSAR. The following lecture has drawn many examples from the online lectures by H. Kubinyi

Transforming Bivariate Data

Predictor Coef StDev T P Constant X S = R-Sq = 0.0% R-Sq(adj) = 0.

Stat 412/512 CASE INFLUENCE STATISTICS. Charlotte Wickham. stat512.cwick.co.nz. Feb

In order to describe motion you need to describe the following properties.

PCHS ALGEBRA PLACEMENT TEST

Section A. Index. Section A. Planning, Budgeting and Forecasting Section A.2 Forecasting techniques Page 1 of 11. EduPristine CMA - Part I

A synonym is a word that has the same or almost the same definition of

Time Series Laboratory

" Y. Notation and Equations for Regression Lecture 11/4. Notation:

Florida Math for College Readiness

Determination of the Mass Percentage of Copper in a Penny. Introduction

SPSS Guide: Regression Analysis

Transcription:

Calculation of Bioavailability Parameters Objectives Determine ka using the Method of Residuals Wagner-Nelson Method Method of Inspection as Appropriate to calculate ka Calculate F using Plasma or Urine Data Understand the difference between absolute and relative bioavailability Fit IV and Oral Data Simultaneously Determine of ka Estimation Method of Residuals Wagner-Nelson Method Method of Inspection Fitting using non-linear regression analysis Chapter 18 1

Method of Residuals Starting with the Equation for Cp Cp = F Dose ka V ( ka kel) e kel t e ka t which can be written as [ ] where Cp = A e kel t A e ka t A = F Dose ka V ( ka kel) Method of Residuals IF ka/kel or kel/ka > 5 AND Both ka and kel are first order Cp = F Dose ka V ( ka kel) [ e kel t e ka t ] Cp at Later Times At later time the exponential with the faster rate constant approaches zero more quickly 1 IF ka > kel 0.8 Slower exponential e ka t 0 and Cp late = A e kel t e (-k' t) 0.6 Faster exponential 0.4 Difference 0.2 0 0 6 12 18 24 Time (hr) Chapter 18 2

Semi-log Plot of Cp versus Time Concentration (mg/l) 100 10 F Dose ka Intercept = V (ka-kel) Cp late kel (from slope) 1 0 1 2 3 4 5 6 7 8 Time (hr) The Next Step Once we determine Cp late from the terminal slope Cp = A e kel t A e ka t since Cp late = A e kel t Cp = Cp late A e ka t or Cp late Cp = A e ka t { Residual Plot Residual versus Time Plot of Residual versus Time Concentration (mg/l) 100 10 1 Feathering ka from slope 0.1 0 1 2 3 4 5 6 7 8 Time (hr) Chapter 18 3

Requirements for the Method of Residuals One Rate Constant at least five times greater than the other Both Absorption and Elimination are first Order Processes Example Data Set Dose 250 mg Time (hr) Plasma Concentration (mg/l) Cp(late) (mg/l) Residual [Col 3 - Col 2] (mg/l) 0.25 1.91 5.23 3.32 0.5 2.98 4.98 2.00 0.75 3.54 4.73 1.19 1.0 3.80 4.50 0.70 1.5 3.84 4.07 0.23 2 3.62 3.69 0.07 3 3.04 4 2.49 Residual = 5.5 e 2.05 t 5.0 2.04 6.0 1.67 7.0 1.37 Cp late = 5.5 e 0.2 t Semi-log Plot 10 Concentration (mg/l) 1 0.1 Cp (mg/l) Cp (late) (mg/l) Residual (mg/l) 0.01 0 1 2 3 4 5 6 7 Time (hr) Chapter 18 4

Wagner-Nelson Method * Advantages: Absorption and Elimination can be quite similar in value Absorption doesn t need to be first order Disadvantages Need to have a value for kel - from IV Data Calculations are more involved * Wagner, J and Nelson, E. 1964 J. Pharm. Sci., 53, 1392 Working Equation Amount Absorbed A Theory Amount In Body X = + Differentiating each term gives da dt or da dt = dx dt + du dt = V dcp + V kel Cp dt Amount Eliminated U Theory (contd) da = V dcp + kel V Cp dt Integrating gives: A = V Cp + kel V or A V = Cp + kel Cp dt t 0 t 0 Cp dt Chapter 18 5

Theory (contd) 2 A V = Cp + kel Cp dt t 0 Amount absorbed Up to time t Divided by V kel x AUC from t = 0 to t = t A max V At t = ; Cp = 0 = kel Cp dt = kel AUC 0 0 If Absorption is First Order (A max -A) is the Amount Remaining to be Absorbed A max V A V = Xg V = Xg0 V e ka t = F Dose e ka t V Plot ln(amax-a)/v versus Time Time (hr) Example Data - W-N Method Concentration (mg/l) kel = 0.2 hr -1 kel = 0.2 hr from I.V. Data -1 from IV data Col 3 AUC Col 4 AUC Col 5 kel AUC A/V [Col2+Col5] 2 + ] (Amax-A)/V (mg/l) 0 0.0 0.0 0.0 0.0 0.0 4.9 1 1.2 0.6 0.6 0.12 1.32 3.58 2 1.8 1.5 2.1 0.42 2.22 2.68 3 2.1 1.95 4.05 0.81 2.91 1.99 4 2.2 2.15 6.2 1.24 3.44 1.46 5 2.2 2.2 8.4 1.68 3.88 1.02 6 2.0 2.1 10.5 2.1 4.1 0.8 8 1.7 3.7 14.2 2.84 4.54 0.36 10 1.3 3.0 17.2 3.44 4.74 0.16 12 1.0 2.3 19.5 3.9 4.9-0.0 5.0 24.5 4.9 4.9 - Chapter 18 6

The Plot - Semi-log ka = 0.3056 hr -1 The Plot - Linear 5 (Amax-A)/V (mg/l) 4 3 2 1 0 0 2 4 6 8 10 Time (hr) By Inspection Assuming ka somewhat larger than kel (>5 times) Assuming absorption complete (> 95%) at time of peak concentration Determine t peak = 5 x t 1/2 (absorption) That is, t 1/2 (absorption) = t peak /5 Chapter 18 7

Example t peak 1.5 hour 40 Concentration (mg/l) 30 20 10 0 0 6 12 18 24 Time (hr) Example t peak 1.5 hour t 1/2 (absorption) 0.3 hour ka 2.3 hr -1 Actual value 2 hr -1 Calculation of F F/V from only Oral Data Need to have Reference Data Absolute Bioavailability Relative Bioavailability Using Plasma Data Using Urine Data Chapter 18 8

F - Bioavailability, Fraction Absorbed Cp = F Dose ka V ( ka kel) [ e kel t e ka t ] From Oral Data Alone Can calculate kel and ka Know Dose Cannot separate F from V We get V/F or F/V Bioavailability (F) Absolute Bioavailability Comparison with IV Dose Relative Bioavailability Comparison with another Extravascular Dosage form Bioavailability Study may use IV, Solution or Innovator s Product as Reference Using Plasma Data Equation for A max from Wagner-Nelson Derivation A max = F Dose = kel V AUC therefore F = kel V AUC Dose Chapter 18 9

Comparing Two Dosage Forms Since we don t know V unless we have prior information F A F B = kela V A AUC A Dose A Dose B kel B V B AUC B If Dose A = Dose B and we can assume that kel A = kel B and V A = V B F = FA F B = AUCA AUC B Example Calculation Data: AUC A = 12.4 mg.hr/l; Dose A = 250 mg; AUC B = 14.1 mg/l; and Dose B = 200 mg Question: Calculate F Equation: Result: F = AUCA Dose A Dose B AUC B F = 12.4 250 x 200 14.1 = 0.70 Using Urine Data Starting with the equation for fe (last semester) U fe = U Xg = 0 F Dose U F = fe Dose F A U A F = B fe A Dose feb Dose B A U B Chapter 18 10

Using Urine Data F A F B = U A fe A Dose feb Dose B A U B If Dose A = Dose B and fe A = fe B F = FA F B = U A U B Example Calculation Data: Dose = 250 mg; U A = 175 mg; U B = 183 mg Question: What is F Equation: F = U A U B Results: F = 175 183 = 0.96 Data Analysis using Boomer Draw the Model - Numbering Components and Data Sets Create Table of Parameters and Constants Start the Program Chapter 18 11

Drug in G-I Tract The Model Dose #1 ka Drug in Body V/F #2 kel #1 Cp Versus Time Parameter Values From Earlier - Method of Residuals ka = 2.05 hr -1 kel = 0.2 hr -1 A = 5.5 mg/l = F Dose ka V ( ka kel) 5.5 = F 250 2.05 V ( 2.05 0.2) V F = 250 2.05 5.5 1.85 = 50.4 L Create the Parameter Table Name Type Value To Name From Dose 1 250 1 ka 2 2.05 2 1 kel 2 0.2 0 2 V/F 18 50.4 1 Cp 2 Chapter 18 12

Fitting Oral Data Alone Using Boomer Open the.bat file Using the SAAM II Start SAAM II Load Program File Fitting Oral and IV Data Together The Model Chapter 18 13

Simultaneous Fit to IV and Oral data Objectives Determine ka using the Method of Residuals Wagner-Nelson Method Method of Inspection as Appropriate to calculate ka Calculate F using Plasma or Urine Data Understand the difference between absolute and relative bioavailability Fit IV and Oral Data Simultaneously Chapter 18 14